TipRanks
Gyre Therapeutics (DE:L9S)
FRANKFURT:L9S
Germany Market
L9S
Gyre Therapeutics
RESEARCH TOOLSreports

Gyre Therapeutics (L9S) Income Statement

1 Followers

Gyre Therapeutics Income Statement

Last quarter (Q2 2026), Gyre Therapeutics's total revenue was $29.11M, a decrease of -2.12% from the same quarter last year. In Q2, Gyre Therapeutics's net income was $-10.61M. See Gyre Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Mar 22
Total Revenue
$ 116.59M$ 105.76M$ 113.45M$ 102.29M$ 7.34M
Gross Profit
$ 111.17M$ 101.87M$ 108.81M$ 97.50M$ -332.00K
Operating Expenses
$ 99.68M$ 85.71M$ 176.04M$ 88.29M$ 83.39M
Depreciation and Amortization
$ 2.48M$ 1.59M$ 1.11M$ 1.13M$ 290.00K
EBITDA
$ 16.92M$ 17.82M$ 20.33M$ 10.54M$ -87.64M
Operating Income
$ 11.49M$ 16.23M$ -67.23M$ 9.20M$ -83.73M
Other Income/Expenses
$ 2.94M$ 6.99M$ -9.73M$ 209.00K$ -4.21M
Pretax Income
$ 14.44M$ 23.22M$ -76.97M$ 9.41M$ -87.93M
Net Income
$ 5.03M$ 12.09M$ -92.93M$ 2.30M$ -87.93M
Per Share Metrics
Basic EPS
$ 0.06$ 0.14$ -1.41$ 0.03$ -2.87
Diluted EPS
$ 0.02$ 0.05$ -1.41$ 0.03$ -2.87
Weighted Average Shares Outstanding
 89.34M 85.09M 65.83M 75.69M 30.64M
Weighted Average Shares Outstanding (Diluted)
 103.18M 102.29M 65.83M 75.69M 30.64M
Currency in USD

Gyre Therapeutics Earnings and Revenue History